Cargando…
Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665255/ http://dx.doi.org/10.1182/blood-2022-159543 |
| _version_ | 1784831251115409408 |
|---|---|
| author | Passerini, Matteo Ratishvili, Tamar Kay, Neil E. Temesgen, Zelalem Witzig, Thomas E. Kennedy, Richard Parikh, Sameer A. |
| author_facet | Passerini, Matteo Ratishvili, Tamar Kay, Neil E. Temesgen, Zelalem Witzig, Thomas E. Kennedy, Richard Parikh, Sameer A. |
| author_sort | Passerini, Matteo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665255 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96652552022-11-16 Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia Passerini, Matteo Ratishvili, Tamar Kay, Neil E. Temesgen, Zelalem Witzig, Thomas E. Kennedy, Richard Parikh, Sameer A. Blood Online Publication Only The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665255/ http://dx.doi.org/10.1182/blood-2022-159543 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Online Publication Only Passerini, Matteo Ratishvili, Tamar Kay, Neil E. Temesgen, Zelalem Witzig, Thomas E. Kennedy, Richard Parikh, Sameer A. Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia |
| title | Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia |
| title_full | Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia |
| title_fullStr | Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia |
| title_full_unstemmed | Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia |
| title_short | Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia |
| title_sort | differences in humoral and cellular response to covid-19 vaccine against different variants over time in chronic lymphocytic leukemia |
| topic | Online Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665255/ http://dx.doi.org/10.1182/blood-2022-159543 |
| work_keys_str_mv | AT passerinimatteo differencesinhumoralandcellularresponsetocovid19vaccineagainstdifferentvariantsovertimeinchroniclymphocyticleukemia AT ratishvilitamar differencesinhumoralandcellularresponsetocovid19vaccineagainstdifferentvariantsovertimeinchroniclymphocyticleukemia AT kayneile differencesinhumoralandcellularresponsetocovid19vaccineagainstdifferentvariantsovertimeinchroniclymphocyticleukemia AT temesgenzelalem differencesinhumoralandcellularresponsetocovid19vaccineagainstdifferentvariantsovertimeinchroniclymphocyticleukemia AT witzigthomase differencesinhumoralandcellularresponsetocovid19vaccineagainstdifferentvariantsovertimeinchroniclymphocyticleukemia AT kennedyrichard differencesinhumoralandcellularresponsetocovid19vaccineagainstdifferentvariantsovertimeinchroniclymphocyticleukemia AT parikhsameera differencesinhumoralandcellularresponsetocovid19vaccineagainstdifferentvariantsovertimeinchroniclymphocyticleukemia |